BUSINESS● LOWSep 11 · Sep 11, 2026, 1:25 PM
Hims & Hers Health resumed at JP Morgan at neutral on GLP-1 compounding headwinds
Seeking Alpha Tech · global
Hims & Hers Health has been rated as 'neutral' by JP Morgan due to challenges related to GLP-1 compounding. This represents an analyst's assessment of the company's financial outlook.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS41m agoNotable analyst calls: Salesforce, Walmart and Lockheed Martin gain analyst support as tech downgrades mountSeeking Alpha TechBUSINESS51m agoInsurance stocks, TransUnion among winners; Banks, IREN in losers: week's financials wrapSeeking Alpha Tech